Gerald McMahon | President and CEO |
Georgia Erbez | CFO |
Natalie Sacks | Chief Medical Officer |
Holger Wesche | Chief Scientific Officer |
Jonathan Chang | SVB Leerink |
Tyler Van Buren | Piper Sandler |
Yigal Nochomovitz | Citigroup |
Asthika Goonewardene | Truist Securities |
Zegbeh Jallah | ROTH Capital Partners |
Arlinda Lee | Canaccord. |
Colleen Kusy | Baird |
Robert Driscoll | Wedbush Securities |
Ladies and gentlemen, thank you for standing by and welcome to the Harpoon Therapeutics 4Q 2020 Financial Results and Corporate Update Conference Call. At this time all participants are in listen-only mode. Please be advised that today’s conference may be recorded. [Operator Instructions] On the call today from Harpoon are Gerry McMahon, President and Chief Executive Officer; Georgia Erbez, Chief Financial Officer, Georgia Erbez, Chief Financial Officer, Natalie Sacks, our Chief Medical Officer and Holger Wesche, our Chief Scientific Officer.
Following management's prepared remarks we will be conducting a Q&A session.